Semaglutide (Wegovy) is a glucagon-like peptide-1 (GLP-1) receptor agonist
Lets break down the differences between Tirzepatide and Retatrutide, focusing on their mechanisms, usage, and effectiveness
Note: This medication guide is for information purposes only
Key takeaways Weaning off tirzepatide should be done under the care and guidance of a healthcare provider
Amit Bakshi, Chairman and Managing Director of Eris Lifesciences, emphasised the strategic importance of the deal, stating: Semaglutide represents one of the most significant therapeutic advances in metabolic care in recent years
Second-Line OTC: Activated Charcoal Activated charcoal (500-520 mg capsules, multiple OTC brands) adsorbs gas and odor compounds in the GI tract through its high surface area